Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 12 (HMGN1P12)

Target
HMGN1P12
Molecular classification
Other (Pseudogene)
01

Overview

High mobility group nucleosome binding domain 1 pseudogene 12 (HMGN1P12) is a pseudogene, which means it is a DNA sequence resembling the functional HMGN1 gene but is not capable of producing a functional protein product[2][3][4]. Pseudogenes like HMGN1P12 may be transcribed into RNA and in some rare cases serve regulatory roles—such as acting as decoys for microRNAs, producing short interfering RNAs, or modulating the stability of homologous gene transcripts through RNA-based mechanisms—but the majority are considered nonfunctional and are not categorized as therapeutic targets[1][4]. There is no evidence indicating that HMGN1P12 encodes a protein or is directly druggable, nor are there any known disease associations or therapeutic implications specific to this pseudogene[2][4]. Key notes: - HMGN1P12 is not a therapeutic target (e.g., not an enzyme, receptor, transporter, or similar). - Common issues for pseudogenes: can complicate genomic studies due to sequence homology[4]. - There is nothing unique about HMGN1P12 to suggest a protein-coding or druggable function; thus, labeling it as a target is incorrect[2][3][4]. If you meant a functional, druggable target such as HMGN1 (without the P12 pseudogene suffix), please clarify.

Other names
HMGN1 pseudogene 12HMGN1P12
02

Biological functions

Potential regulatory RNA roles (e.g., competing endogenous RNA, siRNA or miRNA decoy) (general to pseudogenes)
03

Disease associations

Other (no documented association specific to HMGN1P12; general roles for pseudogenes include possible regulation in cancer and metabolic disease contexts[1][4])

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 12 (HMGN1P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 12 (HMGN1P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call